This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Learn why monthly financial reviews matter for budgeting success. This intro outlines the routine and benefits of regular financial checks.
24,361 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Microsoft kicks off 2026 with a rough start as earnings beat clashes with a surge in capital expenditures. Traders de...
Analysts see SpaceX, OpenAI, and Anthropic pursuing record mega-IPOs in 2026, potentially reshaping liquidity for ven...
Coinbase stock stalls $200 after a 14% surge, with traders watching volume and regulatory headlines for the next move...
Bitcoin mining difficulty drops 7.8% in the latest adjustment, the third weekly decline as miners accelerate an exodu...
A conflict over Iran threatens Asia's access to fertilizer and helium, risking farm yields and semiconductor supply c...
Zscaler executives argue that AI cannot substitute for 100% reliable inline traffic inspection, even as AI workloads ...
The question 'Is corp. stock seriously undervalued?' isn’t easy to answer for FMC. A mix of debt, patent risk, and a ...
Micron’s stock is dropping amid questions about whether Google's new AI memory efficiency could curb DRAM demand. Her...
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
On a downbeat tech day, software stocks proved resilient as cloud demand and subscription revenue buoyed leaders like...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...